Mani Alikhani, D.D.M., D.D.S., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Vibration | 3 | 2019 | 325 | 1.180 |
Why?
|
| X-Ray Microtomography | 4 | 2022 | 428 | 0.980 |
Why?
|
| Osteogenesis | 3 | 2019 | 1299 | 0.950 |
Why?
|
| Maxilla | 4 | 2019 | 469 | 0.850 |
Why?
|
| Mandibular Condyle | 1 | 2022 | 115 | 0.820 |
Why?
|
| Forkhead Transcription Factors | 4 | 2010 | 1613 | 0.640 |
Why?
|
| Osteotomy | 2 | 2014 | 823 | 0.640 |
Why?
|
| Microsurgery | 2 | 2014 | 796 | 0.630 |
Why?
|
| Chondrocytes | 1 | 2022 | 803 | 0.590 |
Why?
|
| Apoptosis | 8 | 2010 | 9715 | 0.580 |
Why?
|
| Femur Head | 1 | 2019 | 301 | 0.570 |
Why?
|
| Orthodontic Wires | 1 | 2015 | 22 | 0.530 |
Why?
|
| Tooth Socket | 1 | 2015 | 124 | 0.500 |
Why?
|
| Tooth Extraction | 1 | 2015 | 222 | 0.490 |
Why?
|
| Bone Remodeling | 1 | 2018 | 575 | 0.480 |
Why?
|
| Fibroblasts | 6 | 2008 | 4143 | 0.460 |
Why?
|
| Osteoblasts | 2 | 2010 | 1163 | 0.440 |
Why?
|
| Alveolar Bone Loss | 1 | 2015 | 383 | 0.430 |
Why?
|
| Tumor Necrosis Factor-alpha | 7 | 2015 | 4414 | 0.400 |
Why?
|
| Rats, Sprague-Dawley | 5 | 2022 | 8300 | 0.370 |
Why?
|
| Calcification, Physiologic | 1 | 2010 | 169 | 0.350 |
Why?
|
| Lumbar Vertebrae | 1 | 2019 | 1844 | 0.350 |
Why?
|
| MAP Kinase Signaling System | 2 | 2006 | 1525 | 0.340 |
Why?
|
| Osteoporosis | 1 | 2019 | 1581 | 0.340 |
Why?
|
| Caspases | 4 | 2006 | 928 | 0.310 |
Why?
|
| Pericytes | 1 | 2010 | 291 | 0.300 |
Why?
|
| Rats | 6 | 2022 | 24265 | 0.280 |
Why?
|
| Alveolar Process | 2 | 2018 | 293 | 0.270 |
Why?
|
| Embryo, Mammalian | 1 | 2010 | 1692 | 0.240 |
Why?
|
| Chemokine CCL5 | 2 | 2015 | 209 | 0.230 |
Why?
|
| Cytosol | 1 | 2006 | 901 | 0.230 |
Why?
|
| Cytokines | 2 | 2015 | 7317 | 0.210 |
Why?
|
| Chemokine CCL2 | 2 | 2015 | 617 | 0.200 |
Why?
|
| Osteoclasts | 2 | 2015 | 729 | 0.200 |
Why?
|
| Stress, Mechanical | 2 | 2018 | 1684 | 0.200 |
Why?
|
| Caspase 3 | 4 | 2006 | 759 | 0.170 |
Why?
|
| Enzyme Activation | 4 | 2006 | 3701 | 0.170 |
Why?
|
| Retina | 1 | 2010 | 2611 | 0.170 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2010 | 3617 | 0.170 |
Why?
|
| Reactive Oxygen Species | 1 | 2006 | 2077 | 0.170 |
Why?
|
| Cartilage | 1 | 2022 | 818 | 0.160 |
Why?
|
| Gene Expression Regulation | 3 | 2008 | 12071 | 0.160 |
Why?
|
| Periodontal Ligament | 1 | 2018 | 118 | 0.150 |
Why?
|
| Orthodontics | 1 | 2018 | 75 | 0.150 |
Why?
|
| Animals | 13 | 2022 | 168561 | 0.140 |
Why?
|
| Ovariectomy | 1 | 2019 | 660 | 0.140 |
Why?
|
| Lipopolysaccharides | 1 | 2003 | 2211 | 0.130 |
Why?
|
| Caspase 9 | 3 | 2004 | 188 | 0.130 |
Why?
|
| Molar, Third | 1 | 2015 | 49 | 0.130 |
Why?
|
| Caspase 8 | 3 | 2004 | 195 | 0.130 |
Why?
|
| Anabolic Agents | 1 | 2018 | 247 | 0.130 |
Why?
|
| Inflammation Mediators | 2 | 2015 | 1889 | 0.130 |
Why?
|
| Acceleration | 1 | 2015 | 181 | 0.130 |
Why?
|
| Molar | 1 | 2015 | 152 | 0.120 |
Why?
|
| RNA | 3 | 2015 | 2747 | 0.120 |
Why?
|
| NF-kappa B | 3 | 2010 | 2500 | 0.120 |
Why?
|
| Physical Stimulation | 1 | 2015 | 525 | 0.120 |
Why?
|
| Chemokine CCL3 | 1 | 2013 | 83 | 0.120 |
Why?
|
| Malocclusion, Angle Class II | 1 | 2013 | 33 | 0.120 |
Why?
|
| Orthodontic Anchorage Procedures | 1 | 2013 | 18 | 0.120 |
Why?
|
| Cuspid | 1 | 2013 | 58 | 0.120 |
Why?
|
| Gingival Crevicular Fluid | 1 | 2013 | 92 | 0.120 |
Why?
|
| Interleukin-1alpha | 1 | 2013 | 84 | 0.110 |
Why?
|
| RANK Ligand | 1 | 2015 | 326 | 0.110 |
Why?
|
| Cell Differentiation | 1 | 2010 | 11470 | 0.110 |
Why?
|
| Cattle | 2 | 2010 | 3923 | 0.110 |
Why?
|
| Bone Resorption | 1 | 2015 | 722 | 0.100 |
Why?
|
| DNA-Binding Proteins | 2 | 2008 | 9639 | 0.100 |
Why?
|
| Interleukin-1 | 1 | 2015 | 1262 | 0.100 |
Why?
|
| Gene Silencing | 2 | 2010 | 1538 | 0.100 |
Why?
|
| Random Allocation | 1 | 2015 | 2425 | 0.100 |
Why?
|
| Interleukin-8 | 1 | 2013 | 689 | 0.090 |
Why?
|
| RNA, Small Interfering | 3 | 2010 | 3504 | 0.090 |
Why?
|
| Core Binding Factor Alpha 1 Subunit | 1 | 2010 | 164 | 0.090 |
Why?
|
| Single-Blind Method | 1 | 2013 | 1589 | 0.090 |
Why?
|
| Collagen | 3 | 2006 | 2684 | 0.090 |
Why?
|
| Microscopy, Fluorescence | 1 | 2015 | 2699 | 0.080 |
Why?
|
| Cells, Cultured | 5 | 2008 | 19223 | 0.080 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 2010 | 452 | 0.080 |
Why?
|
| Interleukin-1beta | 1 | 2013 | 972 | 0.080 |
Why?
|
| Promoter Regions, Genetic | 2 | 2010 | 5867 | 0.080 |
Why?
|
| Fluorescent Dyes | 1 | 2015 | 1915 | 0.080 |
Why?
|
| Antigens, Differentiation | 1 | 2010 | 926 | 0.070 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2010 | 697 | 0.070 |
Why?
|
| Down-Regulation | 2 | 2005 | 3001 | 0.070 |
Why?
|
| Immunohistochemistry | 2 | 2015 | 11363 | 0.070 |
Why?
|
| In Situ Nick-End Labeling | 2 | 2004 | 643 | 0.070 |
Why?
|
| Ceramides | 1 | 2006 | 198 | 0.070 |
Why?
|
| Organ Specificity | 1 | 2010 | 2003 | 0.060 |
Why?
|
| Transcription Factors | 1 | 2005 | 12164 | 0.060 |
Why?
|
| Wound Healing | 1 | 2015 | 2781 | 0.060 |
Why?
|
| Male | 6 | 2018 | 349538 | 0.060 |
Why?
|
| Interleukin-6 | 1 | 2013 | 3199 | 0.060 |
Why?
|
| Cell Line | 2 | 2010 | 15994 | 0.060 |
Why?
|
| Receptors, Immunologic | 2 | 2006 | 1423 | 0.060 |
Why?
|
| Time Factors | 4 | 2013 | 40054 | 0.060 |
Why?
|
| Mice | 6 | 2010 | 81045 | 0.060 |
Why?
|
| Ribonucleases | 1 | 2003 | 287 | 0.050 |
Why?
|
| Signal Transduction | 4 | 2006 | 23387 | 0.050 |
Why?
|
| Protein Kinase Inhibitors | 2 | 2010 | 5522 | 0.050 |
Why?
|
| Mitochondria | 2 | 2005 | 3520 | 0.050 |
Why?
|
| Spectrometry, Fluorescence | 1 | 2003 | 689 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2010 | 2502 | 0.050 |
Why?
|
| Age Factors | 1 | 2018 | 18355 | 0.050 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2005 | 4751 | 0.050 |
Why?
|
| Lysine | 1 | 2004 | 1008 | 0.040 |
Why?
|
| Cytoplasm | 1 | 2004 | 1539 | 0.040 |
Why?
|
| Proteins | 1 | 2015 | 6096 | 0.040 |
Why?
|
| Young Adult | 2 | 2018 | 56350 | 0.040 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2004 | 3920 | 0.040 |
Why?
|
| Adolescent | 2 | 2018 | 85649 | 0.040 |
Why?
|
| Ligands | 1 | 2005 | 3293 | 0.040 |
Why?
|
| Nitric Oxide | 1 | 2006 | 2128 | 0.040 |
Why?
|
| Female | 4 | 2019 | 379592 | 0.040 |
Why?
|
| Repressor Proteins | 1 | 2008 | 3020 | 0.040 |
Why?
|
| Enzyme Inhibitors | 2 | 2004 | 3800 | 0.040 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2006 | 2938 | 0.040 |
Why?
|
| Transfection | 1 | 2005 | 5892 | 0.040 |
Why?
|
| Humans | 10 | 2018 | 742088 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 2 | 2004 | 21821 | 0.030 |
Why?
|
| Up-Regulation | 1 | 2005 | 4211 | 0.030 |
Why?
|
| Middle Aged | 2 | 2018 | 213127 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2013 | 39004 | 0.030 |
Why?
|
| Adult | 2 | 2018 | 213712 | 0.030 |
Why?
|
| Mice, Transgenic | 1 | 2003 | 9735 | 0.020 |
Why?
|
| Transcription, Genetic | 1 | 2005 | 7721 | 0.020 |
Why?
|
| Child | 1 | 2018 | 77478 | 0.020 |
Why?
|
| Aging | 1 | 2004 | 8626 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2004 | 10943 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2004 | 13029 | 0.010 |
Why?
|
| Inflammation | 1 | 2008 | 10578 | 0.010 |
Why?
|